IJsselstein Screening for Central Obesity to detect metabolic syndrome

IJsselstein Screening for Central Obesity to detect metabolic syndrome - IJSCO

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30055

Enrollment

15000

Registered

2006-08-08

Start date

2006-10-09

Completion date

Unknown

Last updated

2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insulin resistance syndrome metabolic syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Men and women aged 20 up to 70 years

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
The MetS prevalence (according to NCEP/ATP III criteria) in the patient population of the MMIJ in IJsselstein aged 20 to 70 years.	—

Secondary

Measure	Time frame
The secondary outcome is the effectiveness of population screening for MetS by general practitioners in a medium-size city in the Netherlands, determined by determinants such as respons rate, sensitivity and specificity of the screening, costs per detected MetS patient and the percentage of patients treated by their GP after 6 months for any diagnosed risk factor.	—

Countries

Netherlands

Outcome results